Urological Surgery
SURGERY
Urological
UROLOGICAL SURGERY
BPH
- Endoscopic resection by laser vaporization
- Outpatient therapy for mild prostatic hypertrophy with sparing of ejaculation
- Aquabeam Waterject for the treatment of severe prostatic hypertrophy and saving of ejaculation
- Outpatient Treatment of BPH: Steam Sclerotization of Prostate Adenoma (REZUM)
Discover the avant-garde treatments for Benign Prostatic Hypertrophy that can make the difference
BPH
Endoscopic resection
by laser vaporization
The modern minimally invasive treatment for benign prostatic hyperplasia (BPH)
Between 40 and 90% of men suffer from the symptoms of benign prostatic hyperplasia. Pharmacological therapy in some of these does not achieve sufficient therapeutic efficacy to guarantee an acceptable quality of life for the patient. In such situations, surgery is the only possibility and of these, greenlight represents one of the most effective minimally invasive therapies with the shortest hospitalization time.
What is greenlight?
Greenlight technology is based on the emission of a laser light through a thin instrument inserted through the urethral meatus, without surgical access with cuts. The laser selectively vaporizes the excess prostate tissue with minimal bleeding, sometimes zero and a hospitalization for the patient of less than 24 hours.


What are the benefits?
Rapidity of surgical execution therefore short operating times.
Hospitalization less than 24 hours.
Minimal bleeding. Results proven by solid scientific foundations.
Minimally invasive procedure without any type of cut or scar.

BPH
Outpatient therapy for mild prostatic hypertrophy with sparing of ejaculation
BPH
Aquabeam Waterject for the treatment of severe prostatic hypertrophy and saving of ejaculation
BPH
Outpatient Treatment of BPH: Steam Sclerotization of Prostate Adenoma (REZUM)
What’s new in the Rezum technique?
The Rezum technique does not involve cutting. The instrument sclerotizes the prostate adenoma by means of steam, forcing it to reduce its volume. The procedure is performed under local anesthesia or mild sedation and in day hospital.
BPH
Soractelite TPLA: Non-surgical treatment of prostatic hypertrophy
The SoracteLite TPLA represents the latest generation of non-invasive non-surgical treatments for the treatment of prostatic hypertrophy. Let’s see together the Echolaser system.
The video shows in detail the automated robotic treatment of benign prostatic hypertrophy (BPH) using the revolutionary Aquabeam system – minimally invasive endoscopic resection system of prostate adenoma using an air jet water (waterject) without the use of thermal energy and operating time of less than 5 minutes. The new system adds to laser therapy in the non-invasive treatment of one of the most common male pathologies.
Discover Soractelite TPLA:
Dr. Andrea Cocci
SoracteLite TPLA: non-surgical treatment of prostatic hypertrophy
The SoracteLite TPLA represents the latest generation of non-invasive non-surgical treatments for the treatment of prostatic hypertrophy. Let’s see together the Echolaser system.
UROLOGY – BPH
Who are the candidates for this procedure?
Patient strongly interested in maintaining hospitalization and in need of rapid recovery times.
What are the disadvantages of the technique?
It will be necessary to keep a catheter in place for a few days just like the other techniques and the simultaneous intake of antibiotics and anti-inflammatory drugs.
Currently, the procedure is totally the responsibility of the patient as it is not reimbursed by the NHS.

